Egle Therapeutics Press Release
2021-10-22

Egle Therapeutics raises 40 million € Series A to develop First-In-Class T-regulatory cells therapies based on Treg-starvers

Egle Therapeutics SAS (Egle), an…
read more
ONA Press Release
2021-10-21

ONA Therapeutics Strengthens Scientific Leadership Team

ONA Therapeutics Strengthens Scientific Leadership…
read more
Fund+ TV
2021-10-19

Fund+ on LN24

Very proud of FundPlus on…
read more
Immunic Press Release
2021-10-15

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

NEW YORK, Oct. 14, 2021…
read more
Coave Press Release
2021-10-12

Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board

Coave Therapeutics appoints Olivier Danos…
read more
Immunic Press Release
2021-10-01

Immunic, Inc. Enrolls First Patient in Its Phase 2 CALLIPER Trial of IMU-838 in Progressive Multiple Sclerosis

NEW YORK, Sept. 30, 2021…
read more
Immunic Press Release
2021-09-22

Immunic and the University Medical Center Goettingen Sign License Agreement Covering the Combination of DHODH Inhibitors and Nucleoside Analogues to Treat Viral Infections, Including COVID-19

Immunic and the University Medical…
read more
Horama Press Release
2021-09-16

Coave Therapeutics and Théa Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigmentosa

Coave Therapeutics and Théa Open…
read more
Exevir Press Release
2021-09-01

ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19

ExeVir Announces First Patient Enrolled…
read more
Cardior Press Release
2021-08-25

Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Cardior Raises €64 M Series…
read more